News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Eva Ciruelos Gil

Articles by Eva Ciruelos Gil

23 ELECTRA: An Open-Label, Multicenter, Phase 1b/2 Study of Elacestrant in Combination With Abemaciclib in Patients With Brain Metastasis From Estrogen Receptor–Positive (ER+), HER2-Negative (HER2) Breast Cancer (BC)

23 ELECTRA: An Open-Label, Multicenter, Phase 1b/2 Study of Elacestrant in Combination With Abemaciclib in Patients With Brain Metastasis From Estrogen Receptor–Positive (ER+), HER2-Negative (HER2) Breast Cancer (BC)

ByNuhad Ibrahim, MD,Sung-Bae Kim,Nancy U. Lin, MD,Ahmad Awada,Eva Ciruelos Gil,Alessandro Di Sanzo,Bartomeu Piza Vallespir,Kathy Puyana Theall,Erika P. Hamilton, MD

August 3rd 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves Revumenib in R/R NPM1-Mutant AML

FDA Approves Belantamab Mafodotin in R/R Multiple Myeloma

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment

FDA Grants Fast Track Designation to MT-125 in Glioblastoma

FDA Grants BTD to Zenocutuzumab in NRG1+ Cholangiocarcinoma

© 2025 MJH Life Sciences^®

All rights reserved.